China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) has priced its Global Depository Receipts (GDRs) on the SIX Swiss Exchange at $14.42 per share. The company aims to raise $92.04 million through the issuance of 638.25 million GDRs.
GDR Issuance Details
The GDRs will be available for trading on September 26. This capital raise marks a significant step for Joincare Pharmaceutical as it seeks to expand its global presence and enhance its financial flexibility.
Future Outlook
The proceeds from the GDR issuance will support Joincare Pharmaceutical’s ongoing initiatives, including research and development, market expansion, and strategic investments. By tapping into the international capital markets, the company aims to strengthen its position in the global pharmaceutical industry.-Fineline Info & Tech